08:00 | Registration |
|
Round Table Discussion -Pharmaceutical Equivalence - What do we need to consider - Moderator : Dr Ajaz Hussain |
| |
09:00 | Pharmaceutical Equivalence - What do we need to consider
Ajaz Hussain, Consultant, Insight Advice & Solutions LLC, United States of America
|
09:01 | Pharmaceutical Equivalence - What do we need to consider
Vipan Dhall, Vice President & Head, Piramal Pharmaceutical Development Services Pvt Ltd, India
|
09:03 | Pharmaceutical Equivalence - What do we need to consider
Venkateswarlu Vobalaboina, Managing Director, Neuheit Pharma Technologies Pvt Ltd, India
|
|
Plenary Talk |
| |
09:30 |  | Keynote Presentation Challenges & Advancements in Complex Generics Formulations
Ajaz Hussain, Consultant, Insight Advice & Solutions LLC, United States of America
|
|
10:10 | Tea Break and Networking in Exhibition Area |
|
Session 1 - Complex Generic Formulations |
| |
10:30 | Current trends,Challenges and Role of Partnering in Development of Complex Generic Formulations for India and Emerging Markets
Harvinder Popli, Managing Director, Zandria Farmaceutica Pvt Ltd, India
|
11:00 | Complex Generics- Pricing Pressures & Cost Reduction Strategies for India Drug Industry
Venkateswarlu Vobalaboina, Managing Director, Neuheit Pharma Technologies Pvt Ltd, India
|
11:30 | Generic ANDA Filing in eCTD Format
Rajashri Ojha, Founder & Director, Raaj Global Pharma Regulatory Affairs Consultants, India
|
|
Session 2 - New Markets and Opportunities for Generics |
| |
12:00 | Exploring New Destination for Generics - Japan Pharmaceutical Market
Praveen Khullar, Senior Director, Sanofi Aventis Group, India
|
12:30 | Contract Research and Manufacturing-Generics & NCE's
Anurag Hitkari, Principal Advisor/Vice President, PragMetis Pharmaserve LLP, India
|
13:00 | Lunch Break and Networking in Exhibition Area |
|
Session 3 - Innovation: Route for Generics Pharma Industry's Success |
| |
14:00 | Innovation: Route for Generic Pharma Industry's Success
Rajeev Raghuvanshi, Vice President, Dr Reddy's Laboratories Ltd, India
|
14:30 | Accelerated Growth through Innovation
Ashish Gogia, Vice President, Cadila Pharmaceuticals Limited, India
|
15:00 | Patenting Complex Generic Products
Mandar Shah, Vice President, Promed Group Ltd., United States of America
|
15:30 | Tea Break and Networking in Exhibition Area |
15:50 | From Biostudies to Biowaivers using IVIVC
Bhupinder Singh Bhoop, Dean, UIPS, Panjab University, India
|
|
Round Table Discussion - Improving Regulatory Predictability for Generics Registration - Moderator : Dr Subir Basak |
| |
16:30 | Improving Regulatory Predictability for Generics Registration
Subir Basak, President, Jubilant Life Sciences Limited, India
|
16:31 | Improving Regulatory Predictability for Generics Registration
Anthony Crasto, Principal Scientist, Glenmark Generics Limited, India
|
16:32 | Improving Regulatory Predictability for Generics Registration
Rajashri Ojha, Founder & Director, Raaj Global Pharma Regulatory Affairs Consultants, India
|
Add to Calendar ▼2014-02-24 00:00:002014-02-24 00:00:00Europe/LondonGenerics - Expanding the Base: Improving Business and Regulatory Predictability for Complex, Niche GenericsSELECTBIOenquiries@selectbiosciences.com
